Identification of target genes of the p16INK4A-pRB-E2F pathway

被引:99
作者
Vernell, R
Helin, K
Müller, H
机构
[1] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[2] FIRC Inst Mol Oncol, I-20139 Milan, Italy
关键词
D O I
10.1074/jbc.M304930200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deregulation of the retinoblastoma protein (pRB) pathway is a hallmark of human cancer. The core members of this pathway include the tumor suppressor protein, pRB, which through binding to a number of cellular proteins, most notably members of the E2F transcription factor family, regulates progression through the cell division cycle. With the aim of identifying transcriptional changes provoked by deregulation of the pRB pathway, we have used cell lines that conditionally express a constitutively active phosphorylation site mutant of pRB (pRBDeltaCDK) or p16(INK4A) (p16). The expression of pRBDeltaCDK and p16 resulted in significant repression and activation of a large number of genes as measured by high density oligonucleotide array analysis. Transcriptional changes were found in genes that are essential for DNA replication and cell proliferation. In agreement with previous results, we found a high degree of overlap between genes regulated by p16 and pRB. Data we have obtained previously for E2F family members showed that 74 of the genes repressed by pRB and p16 were induced by the E2Fs and 23 genes that were induced by pRB and p16 were repressed by the E2Fs. Thus, we have identified 97 genes as physiological targets of the pRB pathway, and the further characterization of these genes should provide insights into how this pathway controls proliferation. We show that Gibbs sampling detects enrichment of several sequence motifs, including E2F consensus binding sites, in the upstream regions of these genes and use this enrichment in an in silico filtering process to refine microarray derived gene lists.
引用
收藏
页码:46124 / 46137
页数:14
相关论文
共 71 条
  • [1] Gli and hedgehog in cancer:: Tumours, embryos and stem cells
    Altaba, AR
    Sánchez, P
    Dahmane, N
    [J]. NATURE REVIEWS CANCER, 2002, 2 (05) : 361 - 372
  • [2] An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice
    Aplan, PD
    Jones, CA
    Chervinsky, DS
    Zhao, XF
    Ellsworth, M
    Wu, CZ
    McGuire, EA
    Gross, KW
    [J]. EMBO JOURNAL, 1997, 16 (09) : 2408 - 2419
  • [3] Signal transduction by the TGF-β superfamily
    Attisano, L
    Wrana, JL
    [J]. SCIENCE, 2002, 296 (5573) : 1646 - 1647
  • [4] THYMOPOIETIN-INDUCED ACQUISITION OF RESPONSIVENESS TO T-CELL MITOGENS
    BASCH, RS
    GOLDSTEIN, G
    [J]. CELLULAR IMMUNOLOGY, 1975, 20 (02) : 218 - 228
  • [5] Role of histone H3 lysine 27 methylation in polycomb-group silencing
    Cao, R
    Wang, LJ
    Wang, HB
    Xia, L
    Erdjument-Bromage, H
    Tempst, P
    Jones, RS
    Zhang, Y
    [J]. SCIENCE, 2002, 298 (5595) : 1039 - 1043
  • [6] E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression
    Chen, CR
    Kang, YB
    Siegel, PM
    Massagué, J
    [J]. CELL, 2002, 110 (01) : 19 - 32
  • [7] Transcriptional regulation and function during the human cell cycle
    Cho, RJ
    Huang, MX
    Campbell, MJ
    Dong, HL
    Steinmetz, L
    Sapinoso, L
    Hampton, G
    Elledge, SJ
    Davis, RW
    Lockhart, DJ
    [J]. NATURE GENETICS, 2001, 27 (01) : 48 - 54
  • [8] The retinoblastoma tumour suppressor in development and cancer
    Classon, M
    Harlow, E
    [J]. NATURE REVIEWS CANCER, 2002, 2 (12) : 910 - 917
  • [9] Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.0.CO
  • [10] 2-I